APAC HRS 2020 Virtual Programs

YOU'RE INVITED

Join us to review and discuss the latest Late-Breaking Clinical Trials below as presented at HRS 2020.

 

Micra CED Comparative Performance

Micra CED study is a study of the Medicare beneficiary population implanted with single-chamber ventricular pacemakers, and will be executed by analyzing administrative claims data. The study consists of two primary objectives: estimate the: (1) acute overall complication rate and (2) the 2-year survival rate of patients implanted with a Micra leadless pacemaker. As part of the secondary objectives of the study, a comparative analysis of Micra leadless pacemakers to single-chamber ventricular transvenous pacemakers will be conducted.

 

BlueSync Field Evaluation Primary Results

The purpose of this field evaluation is to collect and evaluate information related to CareLink transmission compliance as well as patient perceived benefit of BlueSync™ and the health care provider perception of the value of BlueSync™ and satisfaction with BlueSync™.

The evaluation will also assess adoption to remote monitoring, patient perceived benefit of BlueSync™ (how patients interact with the smart device application) and health care provider perception of the value of BlueSync™ and satisfaction with BlueSync™ (benefits experienced by clinicians that use BlueSync™).

 

Pulsed Field Ablation – First in Human

(session not available for ANZ HCPs)

The study is a prospective, multi-center, non-randomized, unblinded worldwide pre-market clinical study. The study will provide first in human insights into clinical safety and device function of the Medtronic PFA system for pulmonary vein isolation (PVI) as a treatment for AF.

Last updated: 
08 May 2020